And protopanaxadiol, as a promising colon cancer inhibitor, it plays an anti colon cancer effect by mediating the interaction between p53 and DR4/DR5 by mediating the necrosis factor-related apoptosis-inducing ligand (TRAIL) pathway (Zhang et al., 2015). Here, TNFRSF10B is linked to colonic neoplasm.